Cambridge Isotope Laboratories

Cambridge Isotope Laboratories, founded in 1981, is a premier chemical manufacturing firm specializing in the production of stable isotopes and stable isotope-labeled compounds. The company provides high-quality reagents and specialized chemical solutions for diverse sectors, including molecular biology, genomics, and clinical diagnostics. Their extensive product portfolio includes NMR solvents, metabolic substrates, and custom-synthesized compounds designed to meet rigorous laboratory standards. By maintaining a focus on precision chemistry, the organization supports complex research and diagnostic applications globally.

Operating with a workforce of 500-1,000 employees, Cambridge Isotope Laboratories maintains a robust operational footprint across 4 locations. The company generates annual revenue of $316.3M, reflecting its significant market share in the specialized chemicals and petrochemicals sector. Their manufacturing processes prioritize high-purity standards, ensuring that all produced isotopes and related compounds are compatible with sensitive analytical instrumentation. This scale allows the firm to serve a broad client base ranging from academic research institutions to large-scale pharmaceutical and biotechnology enterprises.

In a competitive landscape that includes firms like Picarro, SHINE, and New England Biolabs, Cambridge Isotope Laboratories distinguishes itself through technical expertise and consistent product quality. The company continues to innovate within the chemical manufacturing space, leveraging decades of experience to address evolving market demands for isotopically labeled materials. Meet Cambridge Isotope Laboratories's team to learn about the leadership and technical experts driving these advancements. Their commitment to excellence in chemical synthesis remains a cornerstone of their long-term growth strategy within the global scientific community.